TrialScientific reports2026

Association between screening duration and treatment outcomes in the clinical trials of ranibizumab and aflibercept for neovascular age-related macular degeneration.

Hyeong Min Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.